Published in Blood Coagul Fibrinolysis on November 01, 1998
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost (2005) 3.47
Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation. Heart (2007) 1.85
Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol (1999) 1.65
Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation (2001) 1.61
Blood coagulation at the site of microvascular injury: effects of low-dose aspirin. Blood (2001) 1.54
Humoral immunosuppression in men exposed to polycyclic aromatic hydrocarbons and related carcinogens in polluted environments. Environ Health Perspect (1994) 1.49
More on: Fluvastatin inhibits upregulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost (2005) 1.46
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost (2009) 1.28
Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension. Br Heart J (1978) 1.15
Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis. Heart (2008) 1.07
Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance. Am J Respir Crit Care Med (1995) 1.05
Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation (2001) 1.00
Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol J Pharmacol (2001) 0.99
The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review. J Clin Psychiatry (1995) 0.96
Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Heart (2000) 0.96
Hereditary hemorrhagic telangiectasia, factor V Leiden and antiphospholipid syndrome: a case report. Blood Coagul Fibrinolysis (2002) 0.94
Commentary: The risk of over-regulation. BMJ (2011) 0.93
The potential role of statins in contrast nephropathy. Clin Nephrol (2004) 0.93
Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (2000) 0.92
Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol (1997) 0.90
Immune biomarkers in relation to exposure to particulate matter: a cross-sectional survey in 17 cities of Central Europe. Inhal Toxicol (2000) 0.90
Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation. Lancet (1999) 0.89
Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis. J Thromb Haemost (2011) 0.86
Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure. J Lab Clin Med (1980) 0.85
Verapamil normalizes the response of left ventricular early diastolic filling to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (1997) 0.85
Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol J Pharmacol (2001) 0.85
A time-motion study of the activities of attending physicians in an internal medicine and internal medicine-pediatrics resident continuity clinic. Acad Med (2000) 0.84
Impaired response of the forearm resistance but not conductance vessels to reactive hyperemia in hypertrophic cardiomyopathy. Angiology (1999) 0.84
Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy. Heart Vessels (1996) 0.84
Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. J Lab Clin Med (1985) 0.83
Integrins in pulmonary inflammatory diseases. Curr Pharm Des (2005) 0.83
Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy. Heart (2005) 0.82
Antithrombotic actions of statins. Med Sci Monit (2001) 0.82
[Anxiety-depressive disorders in women after hysterectomy. Literature review]. Psychiatr Pol (2002) 0.82
Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit. Am J Physiol (1987) 0.81
Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Lupus (2012) 0.81
Loss of platelet alpha 2-adrenergic receptors during simulated extracorporeal circulation: prevention with prostaglandin E1. J Lab Clin Med (1985) 0.81
Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome. J Thromb Haemost (2010) 0.81
Determinants of depressed left ventricular ejection fraction in pure mitral stenosis with preserved sinus rhythm. J Heart Valve Dis (1996) 0.81
Central nervous system involvement as a major manifestation of rheumatoid arthritis. Rheumatol Int (2007) 0.81
In vivo release and turnover of secreted platelet antiheparin proteins in rhesus monkey (Macaca mulatta). Blood (1980) 0.80
Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy. Int J Cardiol (2004) 0.80
[Anxiety-depressive disorder in women after hysterectomy. Own study]. Psychiatr Pol (2002) 0.79
Heart involvement detected by magnetic resonance in a patient with Churg-Strauss syndrome, mimicking severe asthma exacerbation. Allergy (2009) 0.79
Is serum copper a "trait marker" of unipolar depression? A preliminary clinical study. Pol J Pharmacol (2000) 0.79
Induction of nitric oxide synthase (NOS) and vascular endothelial growth factor (VEGF) in experimental model of angioplasty and heart ischemia. Adv Exp Med Biol (1997) 0.79
Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia. Arterioscler Thromb Vasc Biol (1996) 0.79
An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies. J Thromb Haemost (2011) 0.78
Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects. J Thromb Haemost (2005) 0.78
Advantages of MGuard coronary stent system. Minerva Cardioangiol (2012) 0.78
Effects of acute euglycemic hyperinsulinemia on urinary nitrite/nitrate excretion and plasma endothelin-1 levels in men with essential hypertension and normotensive controls. Metabolism (1999) 0.78
Lack of beneficial effects of L-arginine infusion in primary pulmonary hypertension. Wien Klin Wochenschr (1994) 0.78
Collagen receptors α(1)β(1) and α(2)β(1) integrins are involved in transmigration of peripheral blood eosinophils, but not mononuclear cells through human microvascular endothelial cells monolayer. J Physiol Pharmacol (2012) 0.78
Increased expression of collagen receptors: alpha1beta1 and alpha2beta1 integrins on blood eosinophils in bronchial asthma. Clin Exp Allergy (2006) 0.77
Effects of prostanoids on generation of superoxide ions by human neutrophils. Prog Clin Biol Res (1987) 0.77
The effect of verapamil on response of coronary vasomotion to handgrip exercise in symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (2001) 0.77
Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I. Immunol Res (2015) 0.77
Verapamil improves the response of coronary vasomotion to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (1999) 0.77
[Allergic reactions to gypsum]. Pol Tyg Lek (1975) 0.77
Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines. J Thromb Haemost (2011) 0.77
Effect of having a functioning cadaveric renal transplant on cardiovascular mortality risk in patients on renal replacement therapy. Nephrol Dial Transplant (1995) 0.77
Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus. Lupus (2011) 0.76
[Zinc homeostasis and glutamatergic system in the pathogenesis and treatment of depression]. Psychiatr Pol (2001) 0.76
Use of the Hypomania Checklist-32 and the Mood Disorder Questionnaire for detecting bipolarity in 1051 patients with major depressive disorder. Eur Psychiatry (2011) 0.76
Summary of the 9th meeting of the European Forum on Antiphospholipid Antibodies. Lupus (2014) 0.76
Lung involvement in Churg–Strauss syndrome as related to the activity of the disease. Allergy (2010) 0.76
Simvastatin-induced myopathy in a patient treated for hypercholesterolemia. Morphological aspects. Pol J Pathol (1997) 0.75
Valvular heart disease in systemic lupus erythematosus: another symptom of the disease or a hallmark of secondary antiphospholipid syndrome? Eur Heart J (1997) 0.75
Impairment of coronary microvascular flow in hypertrophic cardiomyopathy. Eur Heart J (2002) 0.75
More on: the debate on antiphospholipid syndrome classification criteria. J Thromb Haemost (2009) 0.75
The risk of alcohol leakage into the left anterior descending coronary artery during non-surgical myocardial reduction in patients with obstructive hypertrophic cardiomyopathy. Eur Heart J (2001) 0.75
Serum cobalt-activated acylase and gamma-glutamyl transpeptidase activities in toxic hepatitis. Gut (1975) 0.75
[Cobalt activated acylase in serum of patients poisoned with mushrooms]. Pol Tyg Lek (1976) 0.75
[Restenosis after coronary balloon angioplasty. Prevention and treatment]. Przegl Lek (2001) 0.75
[Direct stent implantation under control of intracoronary ultrasonography. Immediate and late results]. Przegl Lek (2001) 0.75
[OP.2C.07] THE GROWING RATE OF ATRIAL FIBRILLATION AMONG HEART FAILURE PATIENTS IN POLISH PRIMARY HEALTH CARE - DATA FROM 2005 AND 2013. J Hypertens (2016) 0.75
Determinants of left ventricular function two weeks and one year after an acute myocardial infarction. Angiology (1995) 0.75
[Atrial natriuretic peptide (ANP)--its role under physiologic conditions and certain clinical conditions]. Pol Arch Med Wewn (1993) 0.75
[Intracoronary ultrasound assessment of balloon angioplasty with "stent-like' angiographic result]. Przegl Lek (2001) 0.75
Effects on left ventricular function of pindolol added to verapamil in hypertrophic cardiomyopathy. Am J Cardiol (1993) 0.75
[Eosinophils: their structure, function and clinical evaluation]. Postepy Hig Med Dosw (1976) 0.75
The magnitude of left ventricular myocardial hypertrophy related to the degree of its dysfunction in patients with dilated cardiomyopathy (DCM). Cor Vasa (1992) 0.75
[Primary familial cardiomyopathy]. Kardiol Pol (1976) 0.75
[Platelet activation and endothelial factors in standard exercise test before and after menopause]. Przegl Lek (2001) 0.75
[Clinical predictors of left ventricular function improvement after percutaneous coronary interventions in patients with ejection fraction below 45%]. Przegl Lek (2001) 0.75
[Therapeutic angiogenesis for coronary artery disease. Contemporary results and perspectives]. Przegl Lek (2001) 0.75
Prostacyclin and the fibrinolytic system in ischemic vascular disease. Thromb Res (1983) 0.75
Role of kidney in the catabolic clearance of human platelet antiheparin proteins from rat circulation. Blood (1981) 0.75
Early and late exercise capacity after acute myocardial infarction treated with recombinant tissue-plasminogen activator. Eur Heart J (1994) 0.75
Arachidonate versus ADP-induced platelet aggregation in acute myocardial infarction. Thromb Haemost (1979) 0.75
Plasma ANP and cyclic GMP after physical exercise in patients with mitral valve disease and in healthy subjects. Int J Cardiol (1993) 0.75
Plasma ANP and cyclic GMP levels versus left ventricular performance at different AV delays in AV sequential pacing. Pacing Clin Electrophysiol (1994) 0.75
[Hypertension and other factors of coronary heart disease risk (author's transl)]. Przegl Lek (1975) 0.75
Observer variation in lower limb venography. J Can Assoc Radiol (1981) 0.75
[Percutaneous renal artery angioplasty--review of current indicators]. Przegl Lek (2001) 0.75
[Gastric acid secretion and serum pepsinogen levels in patients with asthma in the course of chronic corticosteroid therapy]. Pol Tyg Lek (1976) 0.75